BRKR – Bruker Corporation
BRKR — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
11.65
Margin Of Safety %
-33
Put/Call OI Ratio
0.16
EPS Next Q Diff
0.24
EPS Last/This Y
2.27
EPS This/Next Y
0.32
Price
60.98
Target Price
55.5
Analyst Recom
2.07
Performance Q
72.35
Upside
-108.7%
Beta
1.28
Ticker: BRKR
19 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-29 | BRKR | 58.9 | 0.49 | 0.08 | 9430 |
| 2026-06-02 | BRKR | 57.33 | 0.26 | 0.09 | 14153 |
| 2026-06-03 | BRKR | 62.67 | 0.26 | 0.01 | 14265 |
| 2026-06-04 | BRKR | 59.94 | 0.20 | 1.72 | 17741 |
| 2026-06-05 | BRKR | 56.38 | 0.29 | 0.62 | 19117 |
| 2026-06-08 | BRKR | 56.29 | 0.30 | 14.40 | 19055 |
| 2026-06-09 | BRKR | 57.27 | 0.34 | 2.34 | 19569 |
| 2026-06-10 | BRKR | 54.93 | 0.37 | 0.05 | 20060 |
| 2026-06-11 | BRKR | 55.17 | 0.34 | 0.41 | 19707 |
| 2026-06-12 | BRKR | 54.23 | 0.34 | 5.75 | 19802 |
| 2026-06-15 | BRKR | 56.58 | 0.31 | 0.07 | 19418 |
| 2026-06-16 | BRKR | 55.79 | 0.31 | 0.07 | 19795 |
| 2026-06-17 | BRKR | 54.74 | 0.30 | 0.33 | 19987 |
| 2026-06-18 | BRKR | 57.2 | 0.30 | 0.23 | 20050 |
| 2026-06-22 | BRKR | 56.57 | 0.14 | 1.19 | 15242 |
| 2026-06-23 | BRKR | 55.07 | 0.16 | 0.00 | 15827 |
| 2026-06-24 | BRKR | 58.46 | 0.16 | 0.07 | 15829 |
| 2026-06-25 | BRKR | 60.85 | 0.16 | 0.35 | 16393 |
| 2026-06-26 | BRKR | 60.94 | 0.16 | 1.91 | 16763 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-29 | BRKR | 58.94 | 20.5 | - | 2.12 |
| 2026-06-01 | BRKR | 58.43 | 20.5 | - | 2.12 |
| 2026-06-02 | BRKR | 57.38 | 20.5 | - | 2.12 |
| 2026-06-03 | BRKR | 62.69 | 20.5 | - | 2.12 |
| 2026-06-04 | BRKR | 59.94 | 20.5 | - | 2.12 |
| 2026-06-05 | BRKR | 56.37 | 20.2 | - | 2.12 |
| 2026-06-08 | BRKR | 56.28 | 20.2 | - | 2.12 |
| 2026-06-09 | BRKR | 57.27 | 20.2 | - | 2.12 |
| 2026-06-10 | BRKR | 54.90 | 20.2 | - | 2.12 |
| 2026-06-11 | BRKR | 55.17 | 20.2 | - | 2.12 |
| 2026-06-12 | BRKR | 54.22 | 20.2 | - | 2.12 |
| 2026-06-15 | BRKR | 56.62 | 20.2 | - | 2.12 |
| 2026-06-16 | BRKR | 55.79 | 20.2 | - | 2.12 |
| 2026-06-17 | BRKR | 54.74 | 20.2 | - | 2.12 |
| 2026-06-18 | BRKR | 57.20 | 20.2 | - | 2.12 |
| 2026-06-22 | BRKR | 56.56 | 20.2 | - | 2.12 |
| 2026-06-23 | BRKR | 55.11 | 20.2 | - | 2.12 |
| 2026-06-24 | BRKR | 58.47 | 20.2 | - | 2.12 |
| 2026-06-25 | BRKR | 60.87 | 20.2 | - | 2.12 |
| 2026-06-26 | BRKR | 60.98 | 19.6 | - | 2.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-29 | BRKR | -0.14 | 0.74 | 12.07 |
| 2026-06-02 | BRKR | -0.14 | 0.04 | 12.07 |
| 2026-06-03 | BRKR | -0.12 | 0.04 | 12.07 |
| 2026-06-04 | BRKR | -0.12 | 0.04 | 12.07 |
| 2026-06-05 | BRKR | -0.12 | 0.04 | 12.07 |
| 2026-06-08 | BRKR | -0.12 | -0.10 | 12.07 |
| 2026-06-09 | BRKR | -0.12 | -0.10 | 12.07 |
| 2026-06-10 | BRKR | -0.12 | -0.10 | 12.37 |
| 2026-06-11 | BRKR | -0.12 | -0.10 | 12.37 |
| 2026-06-12 | BRKR | -0.12 | -0.10 | 12.37 |
| 2026-06-15 | BRKR | -0.12 | -0.15 | 12.37 |
| 2026-06-16 | BRKR | -0.12 | -0.15 | 12.37 |
| 2026-06-17 | BRKR | -0.13 | -0.15 | 12.37 |
| 2026-06-18 | BRKR | -0.13 | -0.15 | 12.37 |
| 2026-06-22 | BRKR | -0.13 | -0.14 | 12.37 |
| 2026-06-23 | BRKR | -0.13 | -0.14 | 12.37 |
| 2026-06-24 | BRKR | -0.13 | -0.14 | 12.37 |
| 2026-06-25 | BRKR | -0.13 | -0.14 | 12.37 |
| 2026-06-26 | BRKR | -0.13 | -0.14 | 11.65 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
19 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.31
Avg. EPS Est. Current Quarter
0.38
Avg. EPS Est. Next Quarter
0.55
Insider Transactions
-0.13
Institutional Transactions
-0.14
Beta
1.28
Average Sales Estimate Current Quarter
853
Average Sales Estimate Next Quarter
897
Fair Value
40.58
Quality Score
53
Growth Score
59
Sentiment Score
87
Actual DrawDown %
35.7
Max Drawdown 5-Year %
-68.7
Target Price
55.5
P/E
Forward P/E
25.01
PEG
1.61
P/S
2.68
P/B
3.79
P/Free Cash Flow
180.74
EPS
-0.24
Average EPS Est. Cur. Y
2.12
EPS Next Y. (Est.)
2.44
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
-1.05
Relative Volume
0.87
Return on Equity vs Sector %
-28.9
Return on Equity vs Industry %
-13.3
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
BRKR
Healthcare
$60.91
📉
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
15/20
Pullback
6/25
Volume
7/15
Valuation
5/20
TP/AR
2/10
Options
5/10
RSI
65.8
Range 1M
79.3%
Sup Dist
2.2%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
12/25
Growth
14/30
Estimates
4/20
Inst/Vol
4/15
Options
7/10
EPS Yr
15.8%
EPS NY
15%
52W%
89.5%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-17.8% upside
Quality
5/30
Valuation
0/30
Growth
12/25
Stability
6/10
LT Trend
4/5
Upside
-17.8%
Quality
53
MoS
-33%
Click a card to see score breakdown
Full Analysis →
BRKR — P/E HistoricalMedical Devices
Sector: Healthcare
Industry: Medical Devices
Employees: 11085
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
BRKR
Latest News
—
Caricamento notizie per BRKR…
stock quote shares BRKR – Bruker Corporation Stock Price stock today
news today BRKR – Bruker Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BRKR – Bruker Corporation yahoo finance google finance
stock history BRKR – Bruker Corporation invest stock market
stock prices BRKR premarket after hours
ticker BRKR fair value insiders trading